Oromucosal Delta9-tetrahydrocannabinol/cannabidiol For Neuropathic Pain Associated With Multiple Sclerosis: An Uncontrolled, Open-label, 2-year Extension Trial

Multiple Sclerosis (MS)

Key Findings

THC/CBD was effective in reducing pains with no evidence of tolerance for the 2 years tested.

Information and Links


Link: Oromucosal Delta9-tetrahydrocannabinol/cannabidiol For Neuropathic Pain Associated With Multiple Sclerosis: An Uncontrolled, Open-label, 2-year Extension Trial

Year: 2007

DOI: 10.1016/j.clinthera.2007.09.013


Ratings

(How Ratings Work)

Multiple Sclerosis (MS) — 5


Demonstrable efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Drugs Used

Sativex (THC:CBD)